Pentoxifylline in flush solution improves early lung allograft function

Annals of Thoracic Surgery

Volumn 61, Issue 4, 1996, Pages 1055-1061

  Yamashita, Motohiro ^a   Schmid, Ralph A ^a   Okabayashi, Kan ^a   Ando, Koei ^a   Kobayashi, Jun ^a   Cooper, Joel D ^a   Patterson, G Alexander ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; PEROXIDASE; VASODILATOR AGENT;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; COMPARATIVE STUDY; CYTOLOGY; DOG; DRUG EFFECT; ENZYMOLOGY; HEMODYNAMICS; LUNG; LUNG LAVAGE; LUNG TRANSPLANTATION; METHODOLOGY; PHYSIOLOGY; REPERFUSION; SOLUTION AND SOLUBILITY; STATISTICS; TIME;

ANALYSIS OF VARIANCE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DOGS; HEMODYNAMIC PROCESSES; LUNG; LUNG TRANSPLANTATION; PENTOXIFYLLINE; PEROXIDASE; REPERFUSION; SOLUTIONS; TIME FACTORS; VASODILATOR AGENTS;

EID: 0030115795     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00015-X     Document Type: Article

References (27)

1. Trulock EP. Recipient selection. In: Patterson GA, Cooper JD, eds. Chest surgery clinics of North America. Philadelphia: Saunders, 1993;3:3.
2. Breda MA, Hall TS, Stuart RS, et al. Twenty-four hour lung preservation by hypothermia and leukocyte depletion. J Heart Transplant 1985;4:325-9.
3. Mandfil G. ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 1988;138:1344-50.
4. Egan TM, Ulicny KS, Lambert CJ, Wilcox BR. Effect of a free radical scavenger on cadaver lung transplantation. Ann Thorac Surg 1993;55:1453-9.
5. Qayumi AK, Jamieson WRE, Poostizadeh A. Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation. Ann Thorac Surg 1991; 52:1026-32.
6. Wang P, Ba ZF, Morrison MH, Ayala A, Chaudy IH. Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 1992;112:451-8.
7. Berens KL, Luke DR. Pentoxifylline in the isolated perfused rat kidney. Transplantation 1990;49:876-9.
8. Okabayashi K, Aoe M, DeMeester SR, Cooper JD, Patterson GA. Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg 1994;59:50-6.
9. Smith PK, Krohn PL, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;50: 71-85.
10. Kraiwz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
11. Date H, Lima O, Matsumura A, Tsuji H, Avignon DA, Cooper JD. In a canine model, lung preservation at 10°C is superior to that at 4°C. J Thorac Cardiovasc Surg 1992;103: 773-80.
12. Veith FJ, Sinha SBP, Graves JS, Boley SJ, Dougherty JC. Ischemic tolerance of the lung: the effect of ventilation and inflation. J Thorac Cardiovasc Surg 1971;61:804-10.
13. Haniuda M, Dresler CM, Mizuta T, Cooper JD, Patterson GA. Free radical-mediated vascular injury in lungs preserved at moderate hypothermia. Ann Thorac Surg 1995;60: 1376-81.
14. Lambert CJ, Egan TM. Optimal timing of administration of free radical scavenger in lung preservation. Transplantation 1992;54:205-9.
15. Detleibach HR, Aviado DM. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 1985;25:8-26.
16. 2 in healthy volunteers. Prostaglandins Leukot Med 1986;22:191-200.
17. Dauber IM, Lesenfsky EJ, Ashmore RC, et al. Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline. J Pharmacol Exp Ther 1992;260:1250-6.
18. Bachmann S, Caldwell-Kenkel JC, Currin RT, et al. Ultrastructural correlates of liver graft failure from storage. Transplant Proc 1993;25:1620-4.
19. Reignier J, Mazmanian M, Detruit H, et al. Reduction of ischemia-reperfusion injury by pentoxifylline in the isolated rat lung. Am J Respir Crit Care Med 1994;150:342-7.
20. Berkenboom G, Unger P, Goldman M, Fang ZY, Fontaine J. Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline. J Cardiovasc Pharmacol 1991;18:761-8.
21. Mizus I, Summer W, Farrukh I, Michael LR, Gurtner GH. Isoproterenol or aminophylline attenuate pulmonary edema after acid lung injury. Am Rev Respir Dis 1985;131:256-9.
22. Michael ED, Hainaeu B, Shu H, Bentzel CJ. Regulation of epithelial tight junction permeability by cyclic AMP. Nature 1981;294:451-3.
23. Kimblad PO, Massa G, Sjoberg T, Steen S. Endothelium-dependent relaxation in pulmonary arteries after lung preservation and transplantation. Ann Thorac Surg 1993;56: 1329-34.
24. Killinger WA, Dorofi DB, Tinsley EA, Keagy BA, Johnson G. Flow cytometric analysis of organ preservation-induced endothelial cell membrane damage. Ann Thorac Surg 1992;53: 472-6.
25. McDonald RJ. Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am Rev Respir Dis 1991; 144:1347-50.
26. Doherty GM, Jensen JC, Alexander HR, et al. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991;110:192-8.
27. Kamphuis J, Smith P, Thien T. Vascular effects of pentoxifylline in humans. J Cardiovasc Pharmacol 1994;24:648-54.